Definium Therapeutics, Inc. · NASDAQ:DFTX
Barrow Robert sold 31,550 Definium Therapeutics, Inc. shares (Form 4)
Traded Sep 25, 2026 · Filed Sep 29, 2026
On Sep 25, 2026, Barrow Robert (Director, Chief Executive Officer) sold 31,550 Definium Therapeutics, Inc. shares at US$36.57 for US$1.15M under a trading plan, leaving 2,213,090 shares. Filed Sep 29, 2026 (Form 4).
- Sold
- 31,550 shares
- Price
- US$36.57
- Value
- US$1.15M
- Holding after
- 2,213,090 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Common Shares | Sale | 31,550 | US$36.57 | 2,213,090 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Barrow Robert
- Definium Therapeutics, Inc. shareholders
- Form 4 · Barrow Robert · Sep 14, 2026
- Form 4 · Barrow Robert · Sep 4, 2026
- Form 4 · Barrow Robert · Aug 12, 2026
- Form 4 · Barrow Robert · Jun 26, 2026
- Form 4 · Barrow Robert · Jun 22, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026
- Form 4 · Krebs Andreas · Sep 18, 2026